Market Place
Sourcing Support
All News #Library
Biotech
Liberate Bio Acquires Myeloid-Optimized CAR Design Licenses
05 Mar 2026 //
PHARMIWEB
Carisma’s Lifeline Disappears as Reverse Merger Plans Break Down
18 Sep 2025 //
FIERCE BIOTECH
Ocugen Updates on Business with Q2 2025 Financial Results
01 Aug 2025 //
GLOBENEWSWIRE
Carisma and OrthoCellix Merge to Target Ortho Cell Therapy
23 Jun 2025 //
GLOBENEWSWIRE
Carisma axes sole clinical candidate, lays off 34% of staff
09 Dec 2024 //
FIERCE BIOTECH
Carisma`s Moderna-powered cell therapy shrinks tumors in mice
07 Nov 2024 //
FIERCE BIOTECH
Carisma And Moderna Expand In Vivo Cell Therapy To Autoimmune Diseases
11 Sep 2024 //
FIERCE BIOTECH
Carisma And Moderna Expand CAR-M Therapy Collaboration
10 Sep 2024 //
PR NEWSWIRE
Carisma Doses First CT-0525 HER2 CAR-Monocyte Patient
16 May 2024 //
PR NEWSWIRE
Carisma New Data At ASGCT Gene And Cell Therapy Meeting
22 Apr 2024 //
PR NEWSWIRE
CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration
14 Dec 2023 //
PR NEWSWIRE
Carisma to Present First Results From in vivo CAR-M Collaboration with Moderna
25 Oct 2023 //
PR NEWSWIRE
Carisma Announces Data from Phase 1 Clinical Trial of CT-0508 at CAR-TCR Summit
01 Sep 2023 //
PR NEWSWIRE
Carisma Announces First Patient Dosed in Ph1 Study of CT-0508 in with KEYTRUDA
28 Jun 2023 //
PR NEWSWIRE
Carisma Reports Fiscal 2022 Financial Results and Recent Business Highlights
04 Apr 2023 //
PR NEWSWIRE
Harvard professor takes on the mantle of Gavi CEO
14 Feb 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.